Advertising
Showing 1 to 5 of 5 entries
  • «
  • 1
  • »
PAST TOP PICK
(A Top Pick May 07/21, Up 14%) Believes company is in process of optimization previous mergers. Covid-19 pandemic has had adverse affect on company, which created a good buying opportunity. As economy re-opens the company will do well. Continues to own the stock.
Healthcare
TOP PICK
Designer, manufacturer, and distributor of lenses, frames, and sunglasses. Market leader. Huge retail presence in Europe and NA. Really strong growth. Strong online presence. Recent acquisition will be transformational. Great story at these levels. Yield is 0.66%.
Healthcare
TOP PICK
Price target: 169.22 Euros A merger of a French lens company and an Italian frame company, including brands Ray Banz, Chanel, Prada and Oakley, The lens business is stable and amounts to 66% of their revenues. The merger wasn't easy, but he expects $500 million in cut costs. They bought Grand Vision, and its 7,000 European stores to make them a major player in lenses and frames. Now, their online sales are nearly #1 in this space. The only business where they lack are contact lenses. ESLOY is well-integrated, with many of their businesses #1 in their categories. There's a trend of people needing glasses because of looking at TV and computer screens.
Healthcare
TOP PICK

Largest global designer, manufacturer, distributor of lenses in the world. Also does frames and sunglasses. These businesses are resilient and have strong growth going forward. Owns franchises such as LensCrafters and Ray-Ban. GrandVision acquisition will be important. Great balance sheet. Yield is 0.71%.

Healthcare
TOP PICK
Merger of the largest lense maker Essilor with the almost monopolistic maker of eyeware frames Luxotica. Together it is a behemoth. They dominate the market and is also the biggest retailer of eyecare with Pearlvision, LenseCrafters, SunglassHut. Huge in sunglasses too. A return to normal stock. (Analysts’ price target is $179.18)
Healthcare
Showing 1 to 5 of 5 entries
  • «
  • 1
  • »

EssilorLuxottica(ESLOY-OTC) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for EssilorLuxottica is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

EssilorLuxottica(ESLOY-OTC) Frequently Asked Questions

What is EssilorLuxottica stock symbol?

EssilorLuxottica is a American stock, trading under the symbol ESLOY-OTC on the US OTC (ESLOY). It is usually referred to as OTC:ESLOY or ESLOY-OTC

Is EssilorLuxottica a buy or a sell?

In the last year, 1 stock analyst published opinions about ESLOY-OTC. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for EssilorLuxottica.

Is EssilorLuxottica a good investment or a top pick?

EssilorLuxottica was recommended as a Top Pick by on . Read the latest stock experts ratings for EssilorLuxottica.

Why is EssilorLuxottica stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is EssilorLuxottica worth watching?

1 stock analyst on Stockchase covered EssilorLuxottica In the last year. It is a trending stock that is worth watching.

What is EssilorLuxottica stock price?

On 2022-01-24, EssilorLuxottica (ESLOY-OTC) stock closed at a price of $96.51.